Drug Type Small molecule drug |
Synonyms SLU PP 332, SLU-PP 332 |
Target |
Action agonists |
Mechanism ERRs agonists(Estrogen-related receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H14N2O2 |
InChIKeyRNZIMBFHRXYRLL-UHFFFAOYSA-N |
CAS Registry303760-60-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Syndrome | Preclinical | United States | 22 Sep 2023 | |
Metabolic Diseases | Preclinical | - | 29 Mar 2023 |